Resources for transition of care
FDA approves GSK's meningococcal ABCWY vaccine
The combination vaccine targets 5 groups of the bacteria Neisseria meningitidis (A,B,C,W, AND Y) that cause the most invasive meningococcal disease cases (IMD) globally.
Food Insecurity and the Dangers of Infant Formula Dilution
Michael Kruer, MD explains genetic testing and cerebral palsy
Genetic research is revealing that up to 35% of cerebral palsy cases have an identifiable genetic cause, leading to earlier diagnoses and potential precision medicine treatments.
Demystifying Infant Formula
Mental health treatment challenges in primary care
Peter S. Jensen, MD, comments on the challenges primary health care providers may face when it comes to mental health treatment in pediatrics, and provides screening tools to consider to combat these challenges.
EN-374 granted rare pediatric disease, orphan drug designations for chronic granulomatous disease
Ensoma's lead program, EN-374, has been granted a pair of FDA designations for the treatment of X-linked chronic granulomatous disease.
